Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

Growth Equity Opportunities V, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
05/12/2023 SC 13D/A Growth Equity Opportunities V, LLC reports a 10% stake in Regulus Therapeutics Inc.
03/09/2023 SC 13D/A Growth Equity Opportunities V, LLC has filed a Schedule 13D for MEI Pharma, Inc.
07/22/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/17/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/09/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/19/2021 SC 13D/A Growth Equity Opportunities V, LLC has filed a Schedule 13D for Trillium Therapeutics Inc.
08/31/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2020 4 Growth Equity Opportunities V, LLC (10% Owner) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Bought 4,398,602 shares @ $0.622, valued at $2.7M
Bought 5,239,254 warrants @ $0.7464, valued at $3.9M
Bought 258,707 options to buy @ $6.22, valued at $1.6M
03/12/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/13/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/04/2020 SC 13D/A Growth Equity Opportunities V, LLC reports a 8.7% stake in Trillium Therapeutics Inc.
12/30/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/15/2019 SC 13D/A Growth Equity Opportunities V, LLC reports a 10% stake in Regulus Therapeutics Inc.
05/09/2019 4 Growth Equity Opportunities V, LLC (10% Owner) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Bought 1,136,704 shares @ $1.08, valued at $1.2M
Bought 3,703,704 warrants @ $1.08, valued at $4M
Bought 256,700 options to buy @ $10.8, valued at $2.8M
03/04/2019 SC 13D/A Growth Equity Opportunities V, LLC reports a 10% stake in Trillium Therapeutics Inc.
05/23/2018 SC 13D Growth Equity Opportunities V, LLC reports a 10% stake in MEI Pharma, Inc.
02/20/2018 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
12/05/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/02/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/31/2017 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy